UB Paderborn / Katalog / Suche / in CDI

Molecular Targeting of Cytotoxic Radiosensitizing Chemotherapies

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S111-S111

2016

Volltextzugriff (PDF)

Extracellular Biosensors to Selectively Radiosensitize Head and Neck Cancers

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.945-945

2016

Volltextzugriff (PDF)

EGFR Targeted Delivery of Ultrapotent Radiosensitizers for Head and Neck Cancer

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S183-S183

2015

Volltextzugriff (PDF)

Clinical and Cosmetic Outcomes in Patients Treated With High Dose Rate Electronic Brachytherapy for Nonmelanoma Skin Cancer

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E634-E634

2015

Volltextzugriff (PDF)

Phase 1 Trial of Attenuated Vaccinia Virus (GL-ONC1) Delivered Intravenously With Concurrent Cisplatin and Radiation Therapy in Patients With Locoregionally Advanced Head-and-Neck Carcinoma

International journal of radiation oncology, biology, physics, 2014-02, Vol.88 (2), p.477-478

2014

Volltextzugriff (PDF)

Tumor Specific Radiosensitization Through Drug Conjugated Activatable Cell Penetrating Peptides

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S173-S173

2014

Volltextzugriff (PDF)

Oncolytic Vaccinia Virus Encoding an Anti-VEGF Antibody Improves the Efficacy of Fractionated Radiation in Lung Tumor Xenografts

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S737-S737

2011

Volltextzugriff (PDF)

Radiotargeting Systemically Administered Oncolytic Vaccinia Virus to Preferentially Replicate in Radiated Gliomas

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S143-S143

2011

Volltextzugriff (PDF)

Increasing the Therapeutic Ratio of Oncolysis by Optimally Integrating Radiotherapy into the Replicative Cycle of Oncolytic HSV-1 for High Grade Gliomas

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S558-S559

2009

Volltextzugriff (PDF)

A Genomic Screening Based Strategy for the Creation of Radiation Inducible Gene Therapy Vectors

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S166-S166

2008

Volltextzugriff (PDF)

Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications

Clinical microbiology and infection, 2002-09, Vol.8 (9), p.551-563

2002

Volltextzugriff (PDF)

Antibody Drug Conjugate Targeted Radiosensitization of HER2 Tumors

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.S148-S148

2017

Volltextzugriff (PDF)

Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1

Gene therapy, 2011-11, Vol.18 (11), p.1098-1102

2011

Volltextzugriff (PDF)

Phase 1 Trial of Attenuated Vaccinia Virus (GL-ONC1) Delivered Intravenously With Concurrent Cisplatin and Radiation Therapy in Patients With Locoregionally Advanced Head-and-Neck Carcinoma: Definitive Management of Head-and-Neck Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2014-02, Vol.88 (2), p.477-478

2014

Volltextzugriff (PDF)

Radiation Assisted Viral Oncolytic Therapy (RaVOLT): IR Activates HSV-1 Viral Promoters to Enhance Viral Replication and Tumor Eradication

International journal of radiation oncology, biology, physics, 2005-10, Vol.63, p.S168-S169

2005

Volltextzugriff (PDF)

2042 A novel therapeutic approach for hepatocellular carcinoma using replication-competent herpes simplex virus and ionizing radiation

International journal of radiation oncology, biology, physics, 1999, Vol.45 (3), p.299-299

1999

Volltextzugriff (PDF)

Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial

Annals of oncology, 2013-04, Vol.24 (4), p.1044-1048

2013

Volltextzugriff (PDF)

Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B‐cell lymphoma treated with R‐CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E‐IPI)

British journal of haematology, 2010-10, Vol.151 (2), p.143-151

2010

Volltextzugriff (PDF)

The Influence of age on Postoperative Morbidity and Mortality After Pancreatoduodenectomy. An Analysis of 6293 Cases from the Acs-Nsqip

The Journal of surgical research, 2012, Vol.172 (2), p.192-192

2012

Volltextzugriff (PDF)

IMPROVED SURVIVAL OUTCOMES FOR PATIENTS WITH EXTRA‐NODAL NK/T LYMPHOMA: DATA FROM 140 PATIENTS PROSPECTIVELY REGISTERED IN THE INTERNATIONAL T‐CELL PROJECT

Hematological oncology, 2017-06, Vol.35 (S2), p.78-79

2017

Volltextzugriff (PDF)

Prognostic Indices in Older DLBCL Patients Receiving R-CHOP: An Analysis of the U.S. Intergroup Study (E4494, CALGB 9793)

Blood, 2006-11, Vol.108 (11), p.813-813

2006

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Molecular Targeting of Cytotoxic Radiosensitizing Chemotherapies

Extracellular Biosensors to Selectively Radiosensitize Head and Neck Cancers

EGFR Targeted Delivery of Ultrapotent Radiosensitizers for Head and Neck Cancer

Clinical and Cosmetic Outcomes in Patients Treated With High Dose Rate Electronic Brachytherapy for Nonmelanoma Skin Cancer

Phase 1 Trial of Attenuated Vaccinia Virus (GL-ONC1) Delivered Intravenously With Concurrent Cisplatin and Radiation Therapy in Patients With Locoregionally Advanced Head-and-Neck Carcinoma

Tumor Specific Radiosensitization Through Drug Conjugated Activatable Cell Penetrating Peptides

Oncolytic Vaccinia Virus Encoding an Anti-VEGF Antibody Improves the Efficacy of Fractionated Radiation in Lung Tumor Xenografts

Radiotargeting Systemically Administered Oncolytic Vaccinia Virus to Preferentially Replicate in Radiated Gliomas

Increasing the Therapeutic Ratio of Oncolysis by Optimally Integrating Radiotherapy into the Replicative Cycle of Oncolytic HSV-1 for High Grade Gliomas

A Genomic Screening Based Strategy for the Creation of Radiation Inducible Gene Therapy Vectors

Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications

Antibody Drug Conjugate Targeted Radiosensitization of HER2 Tumors

Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1

Phase 1 Trial of Attenuated Vaccinia Virus (GL-ONC1) Delivered Intravenously With Concurrent Cisplatin and Radiation Therapy in Patients With Locoregionally Advanced Head-and-Neck Carcinoma: Definitive Management of Head-and-Neck Squamous Cell Carcinoma

Radiation Assisted Viral Oncolytic Therapy (RaVOLT): IR Activates HSV-1 Viral Promoters to Enhance Viral Replication and Tumor Eradication

2042 A novel therapeutic approach for hepatocellular carcinoma using replication-competent herpes simplex virus and ionizing radiation

International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)

Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial

Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B‐cell lymphoma treated with R‐CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E‐IPI)

The Influence of age on Postoperative Morbidity and Mortality After Pancreatoduodenectomy. An Analysis of 6293 Cases from the Acs-Nsqip

IMPROVED SURVIVAL OUTCOMES FOR PATIENTS WITH EXTRA‐NODAL NK/T LYMPHOMA: DATA FROM 140 PATIENTS PROSPECTIVELY REGISTERED IN THE INTERNATIONAL T‐CELL PROJECT

Prognostic Indices in Older DLBCL Patients Receiving R-CHOP: An Analysis of the U.S. Intergroup Study (E4494, CALGB 9793)

Suchergebnisse filtern